New York, New York (PRWEB) September 12, 2013
Nearly 600 Biomet hip lawsuit (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) claims filed on behalf of individuals allegedly injured by the Biomet M2a Magnum Hip Replacement continue to move forward in a multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. On September 9, 2013, the Court issued a Case Management Order that addresses the management of attorney-client privilege and work product protection. The protocols set forth in the Order will govern all cases now pending in the Biomet hip replacement litigation, as well as any lawsuits filed in, removed to, or transferred to the proceeding in the future. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We are representing a number of Biomet hip lawsuit clients in this litigation, and continue to hear from individuals who suffered serious complications, allegedly due to the Biomet M2a Magnum hip. We are pleased with the progress in this proceeding,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential legal evaluations to individuals who may have been injured by this Biomet hip replacement.
Biomet Hip Replacement Lawsuits
The Biomet M2a Magnum hip is a metal-on-metal hip implant, a class of artificial hips that have been the subject of growing safety concerns. In February 2011, the U.S. Food & Drug Administration (FDA) announced it would review these devices, amid concerns that they could shed dangerous amounts of metal debris, leading to serious complications, including premature failure. In January 2013, the FDA announced that its review had indicated that metal-on-metal hips were associated with higher rates of early failure compared to those composed of other materials. The agency also advised patients fitted with all-metal hips to undergo testing for excessive levels of metal in their blood if they experienced any symptoms that would indicate their hip is not performing as it should. In addition, the FDA proposed new guidelines that, if adopted, would impose stricter regulatory controls on metal-on-metal hip implants.
According to court documents, all of the Biomet hip replacement claims pending in the Northern District of Indiana allege that the M2a Magnum’s metal-on-metal design has caused recipients to experience pain and debilitating complications, including chronic pain and metallosis, which often result in early failure of the device and necessitate painful and risky surgery to replace the hip. The proceeding’s next case management conference has been scheduled for September 23, 2013.
Recipients of Biomet hip replacements who have experienced complications like those alleged in Biomet hip lawsuits may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. Learn More about the Biomet hip replacement litigation at Bernstein Liebhard LLP’s website. For additional information and a free case review, please call one our attorneys today at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP